SEC Form 4 · accession 0001437749-26-022670
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Clausen
Officer — CSO/COO
Period of report
Jun 29, 2026
Accepted (ET)
Jul 2, 2026 · 9:31 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001091596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $1.01 | Jun 29, 2026 | A | 65,000 | A | — | Jun 29, 2036 | Common Stock | 65,000 | 65,000 | D |
Explanation of responses
- F1One third of the options are exercisable as of June 30, 2027 and the balance vest quarterly over the subsequent two years.